NAD+ Vial | 1000mg
£70.00
Sale price
£70.00
Regular price
Skip to product information
Administered every 1–3 days
NAD+ Vial | 1000mg
Starting at £50 per vial with a
subscription plan
NAD+ 1000mg research solution, precisely dosed and independently verified by Janoshik Analytical. A bioactive coenzyme studied extensively in published laboratory and metabolic research settings for its role in cellular energy production, mitochondrial function, and healthy aging pathways. For research purposes only.
Meet the NAD+ Pen
-
Ready-to-use research solution
-
≥99% purity, third-party verified
-
Pharmaceutical grade research formulation
-
Free shipping on all UK orders
Pickup currently not available
NAD+ | A naturally occurring coenzyme studied extensively in experimental and preclinical research for its potential role in supporting cellular energy production, mitochondrial function, cognitive performance, and healthy aging pathways. Frequently explored in laboratory models focused on metabolic health, DNA repair, and cellular resilience due to its essential role in energy metabolism and regenerative processes.*
Our compounds are manufactured by Homopeptides and every batch is independently analysed by Janoshik Analytical before reaching you. Janoshik are one of the most respected third-party testing laboratories in the peptide research space — their verification gives you confidence in every order.
This compound is supplied as a lyophilised powder and is intended for reconstitution prior to laboratory use. Store at 2–8°C in a refrigerator, protected from light, heat and moisture. Reconstitute only using an appropriate research-grade diluent immediately before use. Once reconstituted, stability will depend on the selected diluent and storage conditions. For laboratory and research purposes only.*
All orders are dispatched within 1–2 business days. Compounds are packaged with temperature-controlled materials to maintain integrity during transit. Free shipping on all UK orders.
Compounds built for
precision
in whole blood NAD+ concentration recorded in a double-blind randomized crossover trial after 4 weeks of supplementation.*
in mitochondrial activity markers observed in published research investigating NAD+ pathway support and cellular energy metabolism.*
*Based on published peer-reviewed research relating to NAD+ metabolism and cellular energy pathways. Yoshino M et al. “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.” Science. 2021;372:1224–1229. Washington University School of Medicine. For research purposes only. Not for human use. Individual results not implied or guaranteed.
